Abstract
In this issue of Blood, Chapiro et al1 have conducted a comprehensive genetic, clinical, and drug sensitivity analysis of a large series of B-prolymphocytic leukemia (B-PLL) cases and illustrated important new findings with implications for predicting clinical outcome.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1777-1778 |
| Number of pages | 2 |
| Journal | Blood |
| Volume | 134 |
| Issue number | 21 |
| DOIs | |
| State | Published - Nov 21 2019 |
ASJC Scopus subject areas
- Biochemistry
- Immunology
- Hematology
- Cell Biology